Edition:
India

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

6.39USD
2:29am IST
Change (% chg)

$0.10 (+1.59%)
Prev Close
$6.29
Open
$6.31
Day's High
$6.75
Day's Low
$6.27
Volume
667,887
Avg. Vol
318,691
52-wk High
$6.75
52-wk Low
$1.42

Latest Key Developments (Source: Significant Developments)

Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $5.25PER SHARE.  Full Article

Arrowhead Pharma Announces Proposed Underwritten Offering Of Common Stock
Thursday, 18 Jan 2018 

Jan 17 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PROPOSED UNDERWRITTEN OFFERING OF COMMON STOCK.  Full Article

Silence Therapeutics ‍Sells Further Stake In Arrowhead Pharmaceuticals ​
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Silence Therapeutics Plc ::‍SOLD A FURTHER PART OF ITS HOLDING OF COMMON SHARES IN ARROWHEAD PHARMACEUTICALS INC.​.DEAL ‍FOR A TOTAL CONSIDERATION OF $11.3 MILLION​.  Full Article

Arrowhead Pharmaceuticals Files For Regulatory Clearance To Begin Phase 1 Study Of ARO-AAT
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS FILES FOR REGULATORY CLEARANCE TO BEGIN PHASE 1 STUDY OF ARO-AAT.ARROWHEAD PHARMACEUTICALS INC - APPLICATION FOR APPROVAL OF CLINICAL TRIAL WAS SUBMITTED TO NEW ZEALAND MEDICINES AND MEDICAL DEVICES SAFETY AUTHORITY.  Full Article

Silence Therapeutics Cuts Stake In Arrowhead Pharma To 3.7 Pct From 6.4 Pct
Saturday, 9 Dec 2017 

Dec 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC CUTS STAKE IN ARROWHEAD PHARMACEUTICALS TO 3.7 PERCENT AS OF DECEMBER 8 FROM A STAKE OF 6.4 PERCENT AS OF NOVEMBER 29 - SEC FILING.  Full Article

Silence Therapeutics Plc Reports 6.4 Pct Stake In Arrowhead Pharmaceuticals As Of Nov 29
Saturday, 2 Dec 2017 

Dec 1 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC REPORTS 6.4 PERCENT STAKE IN ARROWHEAD PHARMACEUTICALS INC AS OF NOVEMBER 29 - SEC FILING.SILENCE THERAPEUTICS SAYS ACQUIRED ARROWHEAD PHARMACEUTICALS' COMMON STOCK IN ORDER TO FACILITATE DISCUSSIONS REGARDING POSSIBLE TRANSACTION WITH THEM.  Full Article

Arrowhead Pharmaceuticals files for mixed shelf of up to $200 mln - SEC filing
Saturday, 29 Oct 2016 

Arrowhead Pharmaceuticals Inc :Files for mixed shelf of up to $200 million - SEC filing.  Full Article

Arrowhead Pharma files for sale of aggregate of 3 mln shares of co's common stock by selling shareholder Amgen
Saturday, 29 Oct 2016 

Amgen Inc : Arrowhead Pharmaceuticals Inc - Files for sale of aggregate of 3.0 million shares of co's common stock by selling shareholder Amgen Inc - SEC filing .Arrowhead Pharmaceuticals Inc - Co will not receive any proceeds from sale by selling stockholders of shares.  Full Article

Arrowhead Pharmaceuticals announces sale of about 7.6 mln shares
Saturday, 3 Sep 2016 

Arrowhead Pharmaceuticals Inc :Sale of an aggregate of 7.6 million shares of common stock, $0.001 par value per share by selling stockholders - sec filing.  Full Article

Arrowhead Pharma qtrly loss $0.32 per share
Wednesday, 10 Aug 2016 

: Arrowhead reports fiscal 2016 third quarter results .Arrowhead pharmaceuticals inc qtrly basic and diluted loss per share $0.32.  Full Article